Sonoma Pharmaceuticals (SNOA) Change in Inventory (2010 - 2026)
Sonoma Pharmaceuticals' (SNOA) quarterly Change in Inventory came in at -$19000.0 in Q1 2026, up 93.47% year-on-year from -$9820.6 in Q1 2025, and down 147.5% quarter-over-quarter from $40000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Change in Inventory (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Change in Inventory history runs 17 years deep, the most recent figure standing at -$19000.0 for Q1 2026.
- On a quarterly basis, Change in Inventory rose 93.47% year-over-year to -$19000.0 in Q1 2026; TTM through Mar 2026 was $465000.0, a 19.85% increase from a year earlier, with the FY2026 full-year figure at $465000.0, up 19.85% from the prior year.
- Change in Inventory retreated to -$19000.0 in Q1 2026 per SNOA's latest filing, from $40000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $652000.0 in Q2 2025 and bottomed at -$291000.0 in Q1 2025.
- The 5-year median for Change in Inventory is -$19000.0 (2026), against an average of $23705.9.
- Across the five-year window, Change in Inventory jumped 1844.44% in 2022 and tumbled 231.43% in 2023, its largest moves.
- Year by year, Change in Inventory stood at -$285000.0 in 2022, then soared by 274.04% to $496000.0 in 2023, then sank by 37.7% to $309000.0 in 2024, then sank by 87.06% to $40000.0 in 2025, then sank by 147.5% to -$19000.0 in 2026.
- Per Business Quant, the three latest SNOA Change in Inventory figures stand at -$19000.0 (Q1 2026), $40000.0 (Q4 2025), and -$208000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Sonoma Pharmaceuticals | 179.80 | -2.40 Mn | 2.18 Mn | -19,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,000.00 |
| Mar 31, 2026 | -19,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | -208,000.00 |
| Sep 30, 2025 | -208,000.00 |
| Jun 30, 2025 | 652,000.00 |
| Jun 30, 2025 | 652,000.00 |
| Mar 31, 2025 | -291,000.00 |
| Mar 31, 2025 | -291,000.00 |
| Dec 31, 2024 | 309,000.00 |
| Dec 31, 2024 | 309,000.00 |
| Sep 30, 2024 | 256,000.00 |
| Sep 30, 2024 | 256,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 114,000.00 |
| Mar 31, 2024 | -277,000.00 |
| Mar 31, 2024 | -277,000.00 |
| Dec 31, 2023 | 496,000.00 |
| Dec 31, 2023 | 496,000.00 |